Response to: 'Correspondence on: irritable bowel syndrome symptoms in axial spondyloarthritis more common than among healthy controls: is it an overlooked comorbidity?' by Proft et al

Ann Rheum Dis. 2022 Jan;81(1):e10. doi: 10.1136/annrheumdis-2019-216752. Epub 2019 Dec 31.
No abstract available

Keywords: NSAIDs; ankylosing spondylitis; epidemiology; fibromyalgis/pain syndromes; spondyloarthritis.

Publication types

  • Letter
  • Research Support, Non-U.S. Gov't
  • Comment

MeSH terms

  • Axial Spondyloarthritis*
  • Comorbidity
  • Humans
  • Irritable Bowel Syndrome* / epidemiology
  • Spondylarthritis* / epidemiology
  • Spondylitis, Ankylosing* / epidemiology